174 related articles for article (PubMed ID: 27317570)
1. Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles.
Schipper P; van der Maaden K; Romeijn S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
Pharm Res; 2016 Sep; 33(9):2269-79. PubMed ID: 27317570
[TBL] [Abstract][Full Text] [Related]
2. Repeated fractional intradermal dosing of an inactivated polio vaccine by a single hollow microneedle leads to superior immune responses.
Schipper P; van der Maaden K; Romeijn S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
J Control Release; 2016 Nov; 242():141-147. PubMed ID: 27496634
[TBL] [Abstract][Full Text] [Related]
3. Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.
van der Maaden K; Trietsch SJ; Kraan H; Varypataki EM; Romeijn S; Zwier R; van der Linden HJ; Kersten G; Hankemeier T; Jiskoot W; Bouwstra J
Pharm Res; 2014 Jul; 31(7):1846-54. PubMed ID: 24469907
[TBL] [Abstract][Full Text] [Related]
4. Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.
Kouiavskaia D; Mirochnitchenko O; Dragunsky E; Kochba E; Levin Y; Troy S; Chumakov K
J Infect Dis; 2015 May; 211(9):1447-50. PubMed ID: 25391313
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y
J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841
[TBL] [Abstract][Full Text] [Related]
6. The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model.
Norton EB; Bauer DL; Weldon WC; Oberste MS; Lawson LB; Clements JD
Vaccine; 2015 Apr; 33(16):1909-15. PubMed ID: 25765967
[TBL] [Abstract][Full Text] [Related]
7. Intranasal and sublingual delivery of inactivated polio vaccine.
Kraan H; Soema P; Amorij JP; Kersten G
Vaccine; 2017 May; 35(20):2647-2653. PubMed ID: 28400164
[TBL] [Abstract][Full Text] [Related]
8. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats.
Ma Y; Ying Z; Li J; Gu Q; Wang X; Cai L; Shi L; Sun M
Biologicals; 2022 Jan; 75():3-11. PubMed ID: 35058137
[TBL] [Abstract][Full Text] [Related]
10. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
[TBL] [Abstract][Full Text] [Related]
11. Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.
Dietrich J; Andreasen LV; Andersen P; Agger EM
PLoS One; 2014; 9(6):e100879. PubMed ID: 24956110
[TBL] [Abstract][Full Text] [Related]
12. High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.
Muller DA; Fernando GJP; Owens NS; Agyei-Yeboah C; Wei JCJ; Depelsenaire ACI; Forster A; Fahey P; Weldon WC; Oberste MS; Young PR; Kendall MAF
Sci Rep; 2017 Oct; 7(1):12644. PubMed ID: 28974777
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
[TBL] [Abstract][Full Text] [Related]
14. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
15. Intradermal fractional dose inactivated polio vaccine: a review of the literature.
Nelson KS; Janssen JM; Troy SB; Maldonado Y
Vaccine; 2012 Jan; 30(2):121-5. PubMed ID: 22100886
[TBL] [Abstract][Full Text] [Related]
16. Hollow microneedle-mediated micro-injections of a liposomal HPV E7
van der Maaden K; Heuts J; Camps M; Pontier M; Terwisscha van Scheltinga A; Jiskoot W; Ossendorp F; Bouwstra J
J Control Release; 2018 Jan; 269():347-354. PubMed ID: 29174441
[TBL] [Abstract][Full Text] [Related]
17. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.
Muller DA; Pearson FE; Fernando GJ; Agyei-Yeboah C; Owens NS; Corrie SR; Crichton ML; Wei JC; Weldon WC; Oberste MS; Young PR; Kendall MA
Sci Rep; 2016 Feb; 6():22094. PubMed ID: 26911254
[TBL] [Abstract][Full Text] [Related]
18. Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.
Okayasu H; Sein C; Chang Blanc D; Gonzalez AR; Zehrung D; Jarrahian C; Macklin G; Sutter RW
J Infect Dis; 2017 Jul; 216(suppl_1):S161-S167. PubMed ID: 28838185
[TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
Yang C; Shi H; Zhou J; Liang Y; Xu H
Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.
Cadorna-Carlos J; Vidor E; Bonnet MC
Int J Infect Dis; 2012 Feb; 16(2):e110-6. PubMed ID: 22153001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
